1. Home
  2. Analysis
  3. Memantine
  4. Hydroxocobalamin

Memantine and Hydroxocobalamin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Memantine (memantine) and Hydroxocobalamin (hydroxocobalamin). Common drug interactions include agitation among females and pancreatitis acute among males.

The phase IV clinical study analyzes what interactions people have when they take Memantine and Hydroxocobalamin. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Memantine?

Memantine has active ingredients of memantine. It is often used in alzheimer's disease. eHealthMe is studying from 10,266 Memantine users. Check the latest studies of Memantine.

What is Hydroxocobalamin?

Hydroxocobalamin has active ingredients of hydroxocobalamin. It is often used in pernicious anaemia. eHealthMe is studying from 4,273 Hydroxocobalamin users. Check the latest studies of Hydroxocobalamin.

On Jul, 14, 2026

30 people who take Memantine and Hydroxocobalamin together, and have interactions are studied.

Memantine and Hydroxocobalamin drug interactions.

What are the common drug interactions of Memantine and Hydroxocobalamin, by gender? *:

female:

  1. Agitation (state of anxiety or nervous excitement)
  2. Adverse drug reaction
  3. Hip fracture
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Balance disorder
  6. Chemical burn of gastrointestinal tract
  7. Dehydration (dryness resulting from the removal of water)
  8. Depressed level of consciousness
  9. Diarrhoea
  10. Drug administration error

male:

  1. Pancreatitis acute (sudden inflammation of pancreas)
  2. Hallucination (an experience involving the perception of something not present)
  3. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  4. Rash macular (small, flat red spots)
  5. Death
  6. Haematemesis (vomiting of blood)
  7. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)

What are the common drug interactions of Memantine and Hydroxocobalamin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Fall
  2. Mouth ulceration (mouth ulcers)
  3. Hip fracture
  4. Rash macular (small, flat red spots)
  5. Somnolence (a state of near-sleep, a strong desire for sleep)
  6. Balance disorder
  7. Chemical burn of gastrointestinal tract
  8. Death
  9. Dehydration (dryness resulting from the removal of water)
  10. Depressed level of consciousness

What are the existing conditions these people have? *

  1. Osteoporotic Fracture (fracture due to weak bone): 4 people, 13.33%
  2. High Blood Cholesterol: 4 people, 13.33%
  3. Back Pain: 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Memantine and Hydroxocobalamin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Memantine and Hydroxocobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Memantine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydroxocobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Memantine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydroxocobalamin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on memantine and hydroxocobalamin (the active ingredients of Memantine and Hydroxocobalamin, respectively), and Memantine and Hydroxocobalamin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.